Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase
- Авторы: Spasov A.1, Kosolapov V.1, Babkov D.1, Maika O.1
-
Учреждения:
- Volgograd State Medical University, Ministry of Health of the Russian Federation
- Выпуск: Том 163, № 5 (2017)
- Страницы: 695-698
- Раздел: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239198
- DOI: https://doi.org/10.1007/s10517-017-3881-0
- ID: 239198
Цитировать
Аннотация
Validation of the method for studies of glucokinase activators by the spectrophotometric method in an in vitro test system is carried out. The advantage of NAD coenzyme vs. thio-NAD is proven. Manifest activation of glucokinase by MBX-2982 compound (GPR119 agonist) in a wide range of concentrations is demonstrated experimentally.
Об авторах
A. Spasov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Автор, ответственный за переписку.
Email: aspasov@mail.ru
Россия, Volgograd
V. Kosolapov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Россия, Volgograd
D. Babkov
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Россия, Volgograd
O. Maika
Volgograd State Medical University, Ministry of Health of the Russian Federation
Email: aspasov@mail.ru
Россия, Volgograd